6-K
Avricore Health Inc. (AVCRF)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15b-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of: February 2020
Commission File Number: 000-51848
Avricore Health Inc. (Exact name of registrant as specified in its charter)
N/A
(Translation of Registrant’s name into English) 2300 – 1177 West Hastings Street, Vancouver, BC V6E 2K3 CANADA (Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F x Form 40-F o
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes o No x
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes o No x
Indicate by check mark whether the registrant by furnishing the information contained in this Form 6-K is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: Yes o No x
Exhibits
The following exhibits are included in this Form 6-K: 99.1Notice of Meeting, February 5, 2020
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Dated: August 6, 2020 | AVRICORE HEALTH INC. |
|---|---|
| By: /s/ Kiki Smith | |
| Kiki Smith | |
| Chief Financial Officer |
2
February 5, 2020
To: All Canadian Securities Regulatory Authorities
Subject: Avricore Health Inc.
Dear Sirs:
We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:
| 1 | Meeting Type | Annual General and Special Meeting |
|---|---|---|
| 2 | Record Date for Notice of Meeting | February 27, 2020 |
| 3 | Record Date for Voting (If Applicable) | February 27, 2020 |
| 4 | Beneficial Ownership Determination Date | February 27, 2020 |
| 5 | Meeting Date | April 2, 2020 |
| 6 | Meeting Location | 2300-1177 West Hastings St, Vancouver, BC, V6E 2K3 |
| 7 | Voting Securities Details | |
| Description (Class) | Common | |
| ISIN / CUSIP | CA0545211090 / 054521109 | |
| 8 | Issuer sending proxy related materials directly to Non-Objecting Beneficial Owners (NOBO's) | NO |
| 9 | Issuer paying for delivery of Objecting Beneficial<br><br><br>Owners (OBO's) | NO |
| 10 | Notice and Access | |
| Beneficial Holders | NO | |
| Registered Holders | NO |
Sincerely,
“Kiki Smith”
___________________
Avricore Health Inc., CFO
AVRICORE HEALTH INC.
2300-1177 West Hastings St.
Vancouver BC V6E 2K3
T: 604-484-1229